Correlation Between Melisron and Endymed
Can any of the company-specific risk be diversified away by investing in both Melisron and Endymed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Melisron and Endymed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Melisron and Endymed, you can compare the effects of market volatilities on Melisron and Endymed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Melisron with a short position of Endymed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Melisron and Endymed.
Diversification Opportunities for Melisron and Endymed
Poor diversification
The 3 months correlation between Melisron and Endymed is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Melisron and Endymed in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endymed and Melisron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Melisron are associated (or correlated) with Endymed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endymed has no effect on the direction of Melisron i.e., Melisron and Endymed go up and down completely randomly.
Pair Corralation between Melisron and Endymed
Assuming the 90 days trading horizon Melisron is expected to generate 2.63 times less return on investment than Endymed. But when comparing it to its historical volatility, Melisron is 4.61 times less risky than Endymed. It trades about 0.22 of its potential returns per unit of risk. Endymed is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 21,780 in Endymed on September 30, 2024 and sell it today you would earn a total of 7,720 from holding Endymed or generate 35.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Melisron vs. Endymed
Performance |
Timeline |
Melisron |
Endymed |
Melisron and Endymed Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Melisron and Endymed
The main advantage of trading using opposite Melisron and Endymed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Melisron position performs unexpectedly, Endymed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endymed will offset losses from the drop in Endymed's long position.Melisron vs. Azrieli Group | Melisron vs. Delek Group | Melisron vs. Shikun Binui | Melisron vs. Israel Discount Bank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |